Medibank Private shares are expected to soar when they hit the share market after a hugely popular $5.7 billion float.
Thousands of mum and dad retail shareholders have bought the stock for $2 each, a slight discount to the $2.15 price offered to institutional investors.
Brokers are expecting shares to rise in value when they begins trading at noon on Tuesday, in the year's most anticipated public listing.
OptionsXpress market analyst Ben Le Brun predicts the stock will leap towards $2.30, and could hit $2.50 by the end of 2014.
"It's going to capture the hearts and minds of the whole market," he said.
"At this stage, it looks as if it's going to be a very, very successful float."
But Australian Stock Report head of research Chris Conway warns the company faces challenges in achieving real growth in value past $2.30 per share.
"Probably from there, the only way that they're going to be able to make the business more profitable will be by cost cuts," he said.
